Metoprolol Aurobindo

Metoprolol Tartrate, the active ingredient in Metoprolol Aurobindo, is a beta blocker presented as a tablet for oral use. It treats hypertension, angina pectoris, myocardial infarction, heart failure and certain arrhythmias in adult patients.

GNH USA supplies Metoprolol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Tartrate is used to manage cardiovascular conditions that involve excessive sympathetic stimulation.

Hypertension: lowers blood pressure by reducing cardiac output and inhibiting renin release. Angina pectoris: decreases myocardial oxygen demand by slowing heart rate and contractility. Myocardial infarction: reduces risk of recurrent ischemic events through heart‑rate control. Heart failure: improves survival by decreasing ventricular workload. Arrhythmias: stabilises abnormal heart rhythms by blocking β1‑adrenergic receptors.

Metoprolol Tartrate may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Headache - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Allergic reactions (rash, angioedema, anaphylaxis) - Depression or mood changes - Worsening heart failure symptoms

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse events.

Assess cardiovascular status: confirm indication and baseline heart rate/blood pressure. Monitor heart rate and blood pressure regularly during dose titration. Use caution in patients with asthma, COPD, or other bronchospastic disease. Adjust dose in renal or hepatic impairment as needed. Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. Store at ambient temperature: keep in the original container, protect from moisture.

Metoprolol Tartrate can interact with several drug classes; careful review is essential.

Major Interactions (Avoid): - Concomitant AV‑nodal blockers (e.g., verapamil, diltiazem): may cause profound bradycardia. - Clonidine withdrawal: can precipitate severe hypertension. - Insulin or oral hypoglycemics: may mask hypoglycaemia symptoms. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): increase metoprolol plasma levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive efficacy.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance negative chronotropic effect. - Diuretics: can potentiate hypotensive response. - Antidepressants (SSRIs, SNRIs): may require blood pressure monitoring. - Anesthetic agents: may increase risk of intra‑operative bradycardia. - Potassium‑sparing diuretics: monitor serum potassium and cardiac rhythm.